Overexpression of JICD in PC-3 and DU145 cells, patient-derived metastatic prostate carcinoma cell lines, also showed an increase in the protein levels of CD133, by approximately ~1.6-fold and 2.8-fold, respectively (Figure S4D). This evidence concerns the gene PROM1 and metastatic prostate carcinoma.